Evidence level: B
同一个干预,用比率尺度量,所有遗传基线获益相同;用风险差尺度量,遗传负荷越高获益越大。这个”绝对-相对分叉”是体质遗传学必须正面裁决的第一道测量学问题——因为”辨体论治”的增量价值,恰恰取决于分叉点在九种体质间是否对齐。
正文
上一篇文章(#365)给出了辨体论治效应修饰的”标准答案”:相对风险尺度上干预疗效几乎不随遗传负荷改变,绝对风险尺度上高遗传负荷者获益显著更大。但”标准答案”和”完整答案”之间还差一道裁决——这个分叉本身是否稳定、是否在体质亚组间一致。本篇把裁决拆成三块证据。
证据一:相对尺度”平坦”,不是一篇论文的偶然。 Khera 团队在 ARIC、WGHS、MDCS 三个前瞻队列共 55,685 人中检验冠脉疾病遗传风险×生活方式交互:三队列交互 P 分别为 0.38、0.31、0.24,全部落在”无交互”区间;高遗传风险组内,良好生活方式带来 46% 的相对降幅(HR 0.54),十年标准化发病率 10.7%→5.1%(PMID 27959714)。中国人群复现同一现象:阜外医院顾东风团队在 39,755 名中国成人中,理想心血管健康在各 PRS 层的相对 HR 分别为 0.40、0.41、0.36——几乎完全平坦(PMID 36539268)。相对尺度上,干预对所有遗传基线”一视同仁”至少在三套独立人群里站得住。
证据二:绝对尺度”递增”,同样跨人群复现。 同一篇中国队列研究中,绝对风险降幅(ARR)却随 PRS 单调增大:高 PRS 组从 21.1% 降至 8.7%,获益远超低 PRS 组,且 PRS 前 5% 的人群梯度更强(PMID 36539268)。UK Biobank 27.6 万人用增强 PRS 重做:2 型糖尿病的生活方式绝对降幅,top 1% PRS 组 12.4%,底层十分位仅 2.8%,比值超过 4.4 倍(PMID 33433237)。中国慢性病前瞻性研究(CKB)96,400 人则给出方向最极端的数字:从不良转为良好生活方式,高遗传风险组早发冠脉发病率降幅是低风险组的 14.7 倍(PMID 38987358)。三个独立人群、三套设计,绝对尺度全部指向同一结论:遗传负荷越高,每一份生活方式改变的”绝对收益”越大。
证据三:RCT 给出”分叉”的机制注脚——以及一个必须警惕的统计陷阱。 糖尿病预防项目(DPP)823 名强化生活方式干预者中,遗传风险与干预目标的加法交互显著(体重目标 P<0.001、运动目标 P=0.02、三目标全达成 P<0.001):每 100 人年减少的糖尿病病例数随遗传风险三分位递增——1.8、3.1、3.9 例(PMID 33394545)。RADIEL 孕期 RCT 中,干预只在最高遗传风险三分位内显著降低妊娠糖尿病(OR 0.37;交互 P=0.016)(PMID 35501401)。但 T2D-GENE 试验提供了最诚实的一课:973 名男性中,生活方式干预显著降低高遗传风险组 2 型糖尿病(HR 0.30,P<0.001),低风险组却未达显著(HR 0.69,P=0.262)——可两组间的乘法交互检验 P=0.135,不显著(PMID 38888187)。这意味着:相对尺度”平坦”的结论,在 RCT 样本量下可能只是功效不足的假象,而非真实无交互。分叉裁决因此必须同时报告两个尺度,缺一个都会误判。
回到体质:分叉点是否在九种体质间对齐? 以上证据全部建立在”遗传负荷”一个维度上。中医的增量问题在于:痰湿质、阳虚质、阴虚质各自的分叉点(绝对获益开始明显超越相对获益的那个 PRS 百分位)是否一致?若一致,”辨体”与”辨 PRS”指向同一批人,体质分型只是遗传负荷的廉价代理;若不一致——例如痰湿质的分叉点显著左移(代谢位点富集使其”绝对获益陡增”来得更早)——辨体论治就拿到了独立的、不可被 PRS 替代的预测价值。裁决设计:体质×PRS 四分位×随机化干预的交互 RCT,主统计量是各体质亚组内的 RERI(相对超额风险)/AP 与绝对获益-遗传负荷斜率断点,逐体质两两比较分叉点位置(bootstrap CI)。
为什么这道裁决是”辨体论治”的生死线。 如果分叉点在各体质间一致,体质分型本质上只是遗传负荷的另一种写法,多基因评分完全可以替代问卷分型;如果分叉点错位,说明体质携带了 PRS 测不到的额外信号——表观修饰、肠道菌群、生活方式印记——辨体就拥有独立的预测价值。这正是中医与现代遗传学可以平等对话的地方:不是谁取代谁,而是各测各的信号,再比较谁的分叉出现得更早、更陡。对临床的落点也很直接:若分叉左移的体质(如痰湿)被识别出来,该体质人群可以更早进入高强度干预,而”一刀切”策略的浪费与遗漏同时被量化。
证据与局限
已验证: 相对尺度交互不显著在欧美三队列(PMID 27959714,P=0.24-0.38)与中国队列(PMID 36539268,HR 0.36-0.41)复现;绝对获益随 PRS 单调递增在 UK Biobank(PMID 33433237,>4.4 倍)、CKB(PMID 38987358,14.7 倍)、中国队列(PMID 36539268,ARR 梯度)三方复现;RCT 层面高遗传组优先获益(PMID 33394545 加法交互显著;PMID 35501401 仅高风险三分位有效)。
部分验证: T2D-GENE 显示 RCT 中乘法交互检验易功效不足(组间 P=0.135 而高组 HR 0.30 显著,PMID 38888187)——”相对平坦”在多大程度上是统计假象尚无定论;中国队列(PMID 36539268)为观察性设计,ARRT 梯度可能受依从性混杂。
待验证: ①分叉点(绝对获益超过相对获益的 PRS 断点)在痰湿/阳虚/阴虚等体质间是否一致;②体质亚组内 RERI/AP 的显著性检验;③同一干预内相对尺度平坦与绝对尺度递增是否在不同终点(体质评分 vs 代谢指标)间稳定。
相关阅读
- 体质遗传基线越高,干预获益越大还是越小?——体质 PRS 效应修饰检验
- 高/低 PRS 分层的生活方式干预 RCT:遗传负荷高者应答是否衰减
- 体质 PRS 分层 RCT 的”应答衰减斜率”表型异质性裁决
- 研究池子:生物频率密码
证据等级: B(绝对-相对分叉现象有 PubMed 直接支撑;”分叉点在体质亚组间一致性”属可检验假说)
参考文献: PMID 27959714, PMID 33433237, PMID 36539268, PMID 38987358, PMID 33394545, PMID 35501401, PMID 38888187
免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。
Equal Relative Benefit or Absolute Bias Toward High Heritability? Absolute-Relative Forking Decisions Modified by Physical Trait Polygenic Risk Score Effects
Evidence level: B
With a ratio scale, all genetic baselines yield identical intervention benefits; with an absolute risk difference scale, higher genetic burden yields greater benefit. This “absolute-relative fork” represents the first measurement problem that physiological genetics must adjudicate directly—because the incremental value of “constitution-based treatment” hinges precisely on whether the fork point aligns across the nine constitutions.
Main Text
The previous article (#365) provided the “standard answer” regarding effect modification by constitution-based treatment: on a relative risk scale, intervention efficacy remains nearly unchanged regardless of genetic burden, whereas on an absolute risk scale, individuals with higher genetic burden derive significantly greater benefit. However, between the “standard answer” and the “complete answer” lies a critical adjudication: whether this fork itself is stable and consistent across constitution subgroups. This article breaks the adjudication into three strands of evidence.
Evidence 1: The “Flatness” on the Relative Scale is Not an Artifact of a Single Study. Khera et al. tested the interaction between coronary disease genetic risk and lifestyle across three prospective cohorts (ARIC, WGHS, MDCS) totaling 55,685 individuals. The interaction P-values across the three cohorts were 0.38, 0.31, and 0.24 respectively, all falling within the “no interaction” range. Within the high-genetic-risk group, a healthy lifestyle yielded a 46% relative reduction (HR 0.54), lowering the ten-year standardized incidence rate from 10.7% to 5.1% (PMID 27959714). A Chinese population replicated this phenomenon: Dr. Gu Dongfeng’s team at Fuwai Hospital found in 39,755 Chinese adults that the relative HR for ideal cardiovascular health across PRS strata was 0.40, 0.41, and 0.36—nearly perfectly flat (PMID 36539268). On the relative scale, intervention treats all genetic baselines “equally” across at least three independent populations.
Evidence 2: The “Incremental” Trend on the Absolute Scale Also Replicates Across Populations. In the same Chinese cohort study, the absolute risk reduction (ARR) increased monotonically with PRS: the high-PRS group dropped from 21.1% to 8.7%, deriving far greater benefit than the low-PRS group, with a steeper gradient in the top 5% of PRS distribution (PMID 36539268). A re-analysis using enhanced PRS in the UK Biobank (276,000 individuals) showed that for lifestyle interventions regarding type 2 diabetes, the absolute reduction in the top 1% PRS group was 12.4%, compared to only 2.8% in the bottom decile—a ratio exceeding 4.4 times (PMID 33433237). The China Kadoorie Biobank (CKB) with 96,400 individuals provided the most extreme directional figures: shifting from poor to good lifestyle habits resulted in a 14.7-fold greater reduction in early-onset coronary incidence in the high-genetic-risk group compared to the low-risk group (PMID 38987358). Three independent populations and three distinct designs all point to the same conclusion on the absolute scale: higher genetic burden yields greater “absolute yield” for every unit of lifestyle change.
Evidence 3: RCTs Provide Footnotes on the “Fork” Mechanism—and a Statistical Trap to Caution Against. In the Diabetes Prevention Program (DPP) among 823 individuals receiving intensive lifestyle intervention, there was a significant additive interaction between genetic risk and intervention targets (weight goal P<0.001, exercise goal P=0.02, all three goals achieved P<0.001): the number of diabetes cases prevented per 100 person-years increased with each genetic risk tertile—1.8, 3.1, and 3.9 cases respectively (PMID 33394545). In the RADIEL pregnancy RCT, intervention significantly reduced gestational diabetes only within the highest genetic risk tertile (OR 0.37; interaction P=0.016) (PMID 35501401). However, the T2D-GENE trial offered the most honest lesson: among 973 men, lifestyle intervention significantly reduced type 2 diabetes in the high-genetic-risk group (HR 0.30, P<0.001), but did not reach significance in the low-risk group (HR 0.69, P=0.262)—yet the multiplicative interaction test between groups yielded P=0.135, not significant (PMID 38888187). This implies: the conclusion of “flatness” on the relative scale may merely be a false negative due to insufficient power in RCT sample sizes, rather than evidence of true no-interaction. Therefore, the fork adjudication must report both scales simultaneously; omitting either leads to misjudgment.
Returning to Constitution: Does the Fork Point Align Across the Nine Constitutions? The above evidence rests entirely on a single dimension: “genetic burden.” The incremental question in Traditional Chinese Medicine (TCM) is whether the fork points for Phlegm-Dampness, Yang Deficiency, and Yin Deficiency constitutions (the PRS percentile where absolute benefit begins to clearly exceed relative benefit) are consistent. If they align, “constitution-based differentiation” and “PRS differentiation” target the same individuals, making constitution typing merely a cheap proxy for genetic burden. If they do not align—for example, if the fork point for Phlegm-Dampness shifts significantly leftward (due to enrichment at metabolic loci causing “absolute benefit surge” to occur earlier)—then constitution-based treatment secures independent predictive value unreplaceable by PRS. Adjudication design: an RCT with Constitution × PRS Quartile × Randomized Intervention, using RERI (Relative Excess Risk) / AP and the absolute benefit-genetic burden slope breakpoint as primary statistics, comparing fork point positions pairwise across constitution subgroups via bootstrap confidence intervals.
Why This Adjudication Is the Life-or-Death Line for “Constitution-Based Treatment”. If the fork points align across constitutions, constitution typing is essentially just another notation of genetic burden, and polygenic scores can fully replace questionnaire-based typing. If the fork points misalign, it indicates that constitutions carry additional signals undetectable by PRS—epigenetic modifications, gut microbiota signatures, lifestyle imprints—granting constitution-based treatment independent predictive value. This is precisely where TCM and modern genetics can engage in equal dialogue: not one replacing the other, but measuring distinct signals to compare which constitution exhibits the fork appearing earlier and more steeply. The clinical application is equally direct: if constitutions with left-shifted fork points (e.g., Phlegm-Dampness) are identified, those populations can enter high-intensity interventions earlier, while the waste and omission of a “one-size-fits-all” strategy are simultaneously quantified.
Evidence and Limitations
Verified: Non-significant interaction on the relative scale replicated in three Western cohorts (PMID 27959714, P=0.24-0.38) and one Chinese cohort (PMID 36539268, HR 0.36-0.41); monotonic increase in absolute benefit with PRS replicated across UK Biobank (PMID 33433237, >4.4x), CKB (PMID 38987358, 14.7x), and the Chinese cohort (PMID 36539268, ARR gradient). At the RCT level, high-genetic groups prioritize benefit (PMID 33394545 additive interaction significant; PMID 35501401 effective only in high-risk tertile).
Partially Verified: T2D-GENE demonstrates that multiplicative interaction tests in RCTs are prone to insufficient power (group comparison P=0.135 while high-risk group HR 0.30 is significant, PMID 38888187)—the extent to which “relative flatness” is a statistical artifact remains undetermined; the Chinese cohort (PMID 36539268) is observational, so ARRT gradients may be confounded by adherence.
To Be Verified: ① Whether the fork point (PRS breakpoint where absolute benefit exceeds relative benefit) is consistent across constitutions such as Phlegm-Dampness, Yang Deficiency, and Yin Deficiency; ② Significance testing of RERI/AP within constitution subgroups; ③ Stability of the relative scale flatness versus absolute scale increment across different endpoints (constitution scores vs. metabolic indicators) within the same intervention.
Related Reading
- Higher Physiological Baseline, Greater or Smaller Intervention Benefit?—Testing PRS Effect Modification in Constitution
- Lifestyle Intervention RCT Stratified by High/Low PRS: Does Response Attenuate in High Genetic Load
- Adjudicating Phenotypic Heterogeneity via “Response Attenuation Slope” in Constitution-PRS Stratified RCTs
- Research Pool: Biomolecular Frequency Code
Evidence Level: B (Absolute-relative fork phenomenon has direct PubMed support; “consistency of fork point across constitution subgroups” is a testable hypothesis)
References: PMID 27959714, PMID 33433237, PMID 36539268, PMID 38987358, PMID 33394545, PMID 35501401, PMID 38888187
Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.
Leave a Reply